Status:
COMPLETED
Decision Making for Older Adults With Cancer
Lead Sponsor:
University of California, San Francisco
Collaborating Sponsors:
National Institute on Aging (NIA)
Mount Zion Health Fund
Conditions:
Cancer
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
This is a minimal risk, pilot cluster randomized controlled trial (CRT) to determine the feasibility and acceptability of training medical oncologists to use the Best Case/Worst Case-Geriatric Oncolog...
Detailed Description
Primary Objective: I. To assess the feasibility of study procedures and using the BC/WC-GeriOnc communication tool in medical oncology with older adults with cancer. Secondary Objectives I. To eval...
Eligibility Criteria
Inclusion
- Inclusion Criteria for Oncologists:
- Independently practicing medical oncology physician (non-ACGME oncology fellows who practice independently are eligible).
- Annually care for at least 10 patients age \>=65 years with solid tumor malignancies in the outpatient setting (this criterion will be confirmed by oncologist report).
- Willing to complete the two-hour intervention training.
- At the time of enrollment, plans to continue outpatient practice at a University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center (HDFCCC) affiliated site for the duration of the pilot study.
- Inclusion Criteria for Patients:
- Age \>= 65 years.
- Diagnosed with a solid tumor malignancy of any stage.
- 3\. Upcoming decision-making discussion (in-person or via video conferencing) with a participating medical oncologist.
- Able to read, write, and understand English.
- Able to understand and provide written, informed consent. Adequate decisional capacity to consent for this study will be determined using the UCSF Decision-Making Capacity Assessment Tool. Patients with mild cognitive impairment who have adequate decisional capacity to consent for this study will be included.
- There are no performance status, organ function, or comorbidity eligibility criteria for this study.
- During the CRT phase, patients will be given the option to select a caregiver to participate in the study (not required). Caregivers cannot participate without an enrolled patient. Caregivers may be a family member, partner, or friend of the participating patient.
- Inclusion Criteria for Caregivers:
- Age \>=18 years.
- Must plan to be present during the medical oncology decision-making discussion and follow-up visits within the first 3 months.
- Able to read, write, and understand English.
- Able to understand and provide written, informed consent.
- Exclusion Criteria:
- Exclusion Criteria for Oncologists:
- 1\. Medical oncologists who practice solely in the inpatient setting are not eligible.
- Exclusion Criteria for Patients:
- Plan for UCSF second opinion evaluation only. Patients are eligible if they plan to transfer care to UCSF at the time of enrollment.
- Planned decision-making discussion via phone only (without video).
- Patients participating in another cancer communication/decision support intervention study with their medical oncologist.
Exclusion
Key Trial Info
Start Date :
July 6 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 22 2025
Estimated Enrollment :
65 Patients enrolled
Trial Details
Trial ID
NCT05374304
Start Date
July 6 2022
End Date
January 22 2025
Last Update
January 23 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Zuckerberg San Francisco General Hospital
San Francisco, California, United States, 94110
2
San Francisco Veterans Medical Center
San Francisco, California, United States, 94121
3
University of California, San Francisco
San Francisco, California, United States, 94143